Saturday, 25th of May 2013 |
A report of the December 2012 GACVS meeting was presented.
SAGE acknowledged the detailed review and the recommendations of GACVS on the safety profile of varicella vaccines, risk of narcolepsy and Guillain-Barré syndrome with influenza vaccines, and the safety of dengue vaccines.
SAGE suggested that future recommendations on dengue vaccine safety be linked to the dengue vaccine development strategy. SAGE stressed that the development of guidelines for the use of vaccines in pregnant women needs to be accelerated and recognized that while GACVS is focusing on specific vaccines, more generic guidance about the use of different vaccines in pregnant women should be developed by SAGE to complement this work.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41138315 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |